secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbCellera Biologics Inc. (ABCL)
CIK:        0001703057
Form:       8-K
Filed at:   2026-06-12T16:12:02+00:00
Accession:  0001703057-26-000033
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

AbCellera shareholders elect two Class III directors, ratify EY, approve say-on-pay
--------------------------------------------------------------------------------

- John S. Montalbano elected with 141.4M for, 12.7M against; Stephen R. Quake with 149.0M for, 5.1M against.
- Ratification of Ernst & Young as independent auditor for FY2026: 190.0M for, 0.6M against.
- Advisory say-on-pay approved: 142.8M for, 10.9M against, with 36.6M broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1703057/000170305726000033/0001703057-26-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1703057/000170305726000033/abcl-20260611.htm
  HTML page:      https://secwatch.observer/filing/0001703057-26-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer